Polar Asset Management Partners’s AEON Biopharma Inc AEON.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-27,348
Closed -$41.7K 922
2024
Q1
$41.7K Hold
27,348
﹤0.01% 596
2023
Q4
$2.39K Hold
27,348
﹤0.01% 764
2023
Q3
$4.37K Hold
27,348
﹤0.01% 836
2023
Q2
$2.46K Hold
27,348
﹤0.01% 944
2023
Q1
$1.5K Hold
27,348
﹤0.01% 1040
2022
Q4
$1.25K Hold
27,348
﹤0.01% 1212
2022
Q3
$2K Hold
27,348
﹤0.01% 1363
2022
Q2
$4K Hold
27,348
﹤0.01% 1338
2022
Q1
$8K Sell
27,348
-9,000
-25% -$3.71K ﹤0.01% 1183
2021
Q4
$19K Sell
36,348
-113,552
-76% -$62.7K ﹤0.01% 1276
2021
Q3
$88K Hold
149,900
﹤0.01% 1111
2021
Q2
$150K Buy
+149,900
New +$114K ﹤0.01% 978

Polar Asset Management Partners's AEON.WS Position: Q2 2024 in Review

Polar Asset Management Partners sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 27,348 shares — an estimated $41.7K sold.

Polar Asset Management Partners first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $150K in Q2 2021. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Polar Asset Management Partners reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Polar Asset Management Partners sold 27,348 AEON Biopharma Inc shares in Q2 2024, an estimated $41.7K.
  • Polar Asset Management Partners first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
  • Polar Asset Management Partners's AEON Biopharma Inc position peaked at $150K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Polar Asset Management Partners's 13F filing for Q2 2024, filed 14 Aug 2024.